Novo Nordisk A/S (NONOF)
43.50
-1.14
(-2.56%)
USD |
OTCM |
May 20, 15:59
Novo Nordisk EPS Diluted (Quarterly) : 1.709 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| ALK-Abello A/S | 0.3088 |
| H. Lundbeck A/S | 0.2616 |
| Dr. Reddy's Laboratories Ltd. | 0.0288 |
| AstraZeneca PLC | 0.9849 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.604B |
| Revenue (Quarterly) | 15.16B |
| Total Expenses (Quarterly) | 7.558B |
| Enterprise Value | 217.09B |
| Gross Profit Margin (Quarterly) | 85.96% |
| Profit Margin (Quarterly) | 50.15% |
| Earnings Yield | 9.80% |
| Operating Earnings Yield | 11.96% |
| Normalized Earnings Yield | 9.797 |